| Patients with BMD z-score <-2 (N = 19) N (%) | Patients with BMD z-score >-2 (N = 41) N (%) | P | OR (95% CI) |
---|---|---|---|---|
T950C (rs2073617) |  |  | < 0.001 |  |
Genotypes: | Â | Â | Â | Â |
TT TC CC | 14(73.7%) 3(15.8%) 2(10.5%) | 8(19.5%) 18(43.9%) 15(36.5%) | < 0.001 0.04 0.05 | 11.5(3.2–41.6) 0.2(0.06–0.95) 0.2(0.04–1.007) |
Alleles: | Â | Â | Â | Â |
T allele C allele | 31(81.6%) 7(18.4%) | 34(41.5%) 48(58.5%) | < 0.001 | 6.2(2.5–15.9) |
T245G (rs3134069) | Â | Â | 0.96 | Â |
Genotypes: | Â | Â | Â | Â |
TT TG GG | 4(21%) 9(47.4%) 6(31.6%) | 8(19.5%) 21(51.2%) 12(29.3%) | 0.89 0.78 0.86 | 1.1(0.29–4.2) 0.86(0.29–2.5) 1.1(0.34–3.6) |
Alleles: | Â | Â | Â | Â |
T allele G allele | 17(44.7%) 21(55.3%) | 37(45.1%) 45(54.9%) | 0.97 | 0.96(0.45–2.1) |
RANKL (ng/L) OPG (ng/L) RANKL/OPG | 129.2 ± 101.4 5.4 ± 3.6 27.7 ± 25.7 | 65.7 ± 78.6 7.6 ± 5.8 10.6 ± 14.7 | 0.01 0.12 0.002 | (15.5-111.4) (-5.1-0.6) (4.03–30.2) |
Sex male/female N(%) | 3(15.8%)/16(84.2%) | 19(64.3%)/22(53.7%) | 0.02 | 0.22(0.06–0.86) |
Age at diagnosis/years | 8.5 ± 3.3 | 7.3 ± 3.2 | 0.2 | (-0.7- 2.9) |
Duration of illness (months) Above/below 36 months N(%) | 64.4 ± 32.1 16(84.2%)/3(15.8%) | 48.6 ± 34.4 20(48.8%)/21(51.2%) | 0.09 0.009 | 8.8(-2.9- 34.5) 6.7(1.1–12.9) |
BMI Z-score | 1.1 ± 1.01 | 0.79 ± 1.34 | 0.37 | 0.2(-1–0.38) |
Type of onset: n (%) | Â | Â | Â | Â |
Systemic Polyarticular Oligoarticular Psoriatic Enthesitis-related arthropathy | 11(52.6%) 6(31.6%) 2(15.8%) 0 0 | 12(29.3%) 16(39%) 9(22.1%) 2(4.8%) 2(4.8%) | 0.03* 0.57** 0.29*** | 2.7(0.87–8.2) 0.7(0.2–2.3) 0.7(0.16–2.8) |
Steroid use yes/no, N(%) Methotrexate use yes/no N(%) Biological treatment yes/no, N(%) | 17(89.5%)/2(10.5%) 16(84.2%)/3(15.8%) 5(26.3%)/14(73.7%) | 24(58.5%)/17(41.5%) 32(78%)/9(22%) 7 (17.1%)/34(82.9%) | 0.02 0.58 0.41 | 6.02(1.2–29.6) 1.5(0.35–6.3) 1.7(0.47–6.4) |
Cumulative steroid dose (mg/kg) | 75.7 ± 24.1 | 38.1 ± 16.1 | 0.003 | 5.6(6.9-32.25) |
Number of swollen joints | 3.3 ± 4.8 | 2.02 ± 3.5 | 0.3 | 1.3(-0.96-3.4) |
Number of tender joints | 4.3 ± 4.6 | 2.7 ± 3.7 | 0.15 | 0.9(1.6–1.2) |
Number of joints with limited mobility | 2.05 ± 3.3 | 1.2 ± 2.4 | 0.3 | 0.3(-0.72-2.3) |
Rheumatoid factor + ve/-ve N(%) | 6(31.6%)/13(68.4%) | 13(31.7%)/28(68.3%) | 0.9 | 1.1(0.4–3.3) |
JADAS-27 | 14.9 ± 13.5 | 15.4 ± 12.4 | 0.9 | 1.8(-7.8 -6.9) |
Damage index | Â | Â | Â | Â |
Articular Extraarticular | 12.8 ± 10.5 3.2 ± 2.3 | 5.7 ± 8.7 1.8 ± 1.7 | 0.008 0.009 | 0.8(1.9–12.2) 1.3(0.4–2.5) |